Sort
35,931 grants matching “parkinsons”
Therapy of Movement Disorders
$494,521Mark Hallett · National Institute Of Neurological Disorders And Stroke · ZIA · FY2009 · NS
Protein Structure, Stability, and Amyloid Formation
$494,510Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
PET Imaging MDMA Neurotoxicity
$494,496Johns Hopkins University · R01 · FY2004 · DA
Mechanisms and Regulation of Brain Iron Uptake
$494,496James R Connor · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2015 · NS
Validating New NIH Clinical Tools in Parkinson's Disease with/without Depressio
$494,488Mustafa M. Husain · Ut Southwestern Medical Center · RC1 · FY2009 · NS
Thermo Vantage triple quadrupole with FAIMS and Accela UPLC
$494,474Kym Francis Faull · University Of California Los Angeles · S10 · FY2010 · RR
Analyzer for monitoring personal environmental exposure to fluids and materials
$494,457Zewu Chen · X-Ray Optical Systems, Inc. · R44 · FY2010 · ES
Uncovering the Neural Mechanisms that Flexibly Link Sensory Processing to Behavior
$494,450Mala Murthy · Princeton University · R35 · FY2019 · NS
Deep Brain Stimulation in Parkinson's Models
$494,404University Of Washington · R01 · FY2005 · NS
Thalamo-Cortical Plasticity: Sensory Denervation and Loss of Dopamine
$494,270Judith Richmon Walters · National Institute Of Neurological Disorders And Stroke · ZIA · FY2010 · NS
Neuronal Activity in MC and SMA during STN and GPi DBS in the Parkinsonian Monkey
$494,251Jerrold L Vitek · University Of Minnesota · R01 · FY2016 · NS
Molecular Studies of Spinocerebellar Ataxia Type 1
$494,212Huda Y Zoghbi · Baylor College Of Medicine · R01 · FY2014 · NS
Role of meningeal lymphatic vasculature in neuroimmune communication development
$494,067Jean-Leon Thomas · Yale University · R01 · FY2025 · NS
Chaperone-mediated Autophagy and Synaptic Dysfunction in Parkinson's Disease
$494,046Zixu Mao · Emory University · R01 · FY2022 · NS
Gene Therapy for Idiopathic Parkinson's Disease
$494,040Victoria M Bolotina · Mark Therapeutics, Inc. · R43 · FY2024 · NS
New Approach to PD Neuroprotection using Cell Type Specific Analysis
$494,016Ole Isacson · Mclean Hospital · P50 · FY2007 · NS
Multi-modal, large-scale characterization of cellular and cell-type-specific effects with electric stimulation in rodent and human brain
$494,011Soo Yeun Lee · Allen Institute · R01 · FY2024 · NS
Manipulating autophagy in human neurons to determine subtype-specific neurodegenerative disease phenotypes
$493,900Lorenz P. Studer · Sloan-Kettering Inst Can Research · R21 · FY2020 · NS
High-throughput screening for NAD+-replenishing neuroprotective compounds
$493,891Corinne Ida Lasmezas · Scripps Florida · R01 · FY2016 · NS
MITOCHONDRIAL OXIDATIVE STRESS AND NEURODEGENERATION
$493,862Buck Institute For Age Research · R01 · FY2003 · AG
Developmental underpinnings of substantia nigra vulnerability
$493,815Rajeshwar B Awatramani · Northwestern University At Chicago · R01 · FY2023 · NS
Physiology of Single Synaptic CNS Terminals
$493,813Timothy A Ryan · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · NS
Physiology of Single Synaptic CNS Terminals
$493,813Timothy A Ryan · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · NS
In vivo and in vitro systems to validate geronic proteins and their mechanisms of action
$493,758Tamas L Horvath · Yale University · R56 · FY2016 · AG
Pathophysiology Informed Biomarkers of Treatment Response in Early Psychosis (PIB)
$493,660Cameron S. Carter · University Of California-Irvine · R01 · FY2023 · MH